October 22, 2026

Advancing Pulmonary Vascular Disease Care Through Research

Pulmonary vascular disease is a rapidly evolving field, with emerging therapies, new diagnostic approaches and ongoing research reshaping how patients with pulmonary hypertension are evaluated and treated.

Temple Health

October 08, 2026

Hot tub lung may mimic refractory pneumonitis

Rare MAC organisms on lung biopsy and an overlooked exposure history shifted the diagnosis after prolonged immunosuppression.

MDSpire News

October 01, 2026

Medical Oddities: Long workweeks meet erectile function

From work stress to lullabies, bay leaves, and one-legged cycling, medicine gets weird.

MDSpire News

September 29, 2026

Top 10 evidence-based essentials in pulmonology

A structured framework of guidelines, trials, therapies, and tools used in clinical practice.

MDSpire News

August 12, 2026

Can Treprostinil Change IPF Care?

Inhaled treprostinil resulted in a smaller decline in lung function and fewer clinical‐worsening events than placebo over 52 weeks.

MDSpire News

July 13, 2026

Side Effects: Signals in Strange Places

From breathier speech to breastfeeding history, metamaterial eye coils, and antifibrotic GLP-1 effects in mice, this week’s studies remind us that the most interesting signal is often hiding somewhere clinicians were not looking.

MDSpire News

June 19, 2026

First HIV-Positive-to-HIV-Positive Lung Transplant Reported

The procedure was performed under a HOPE Act research protocol at an NYU Langone Health center the institution said is among the limited number of US transplant centers equipped and approved to perform HOPE lung transplants.

MDSpire News

June 11, 2026

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

MDSpire News

May 29, 2026

RA Prescribing Patterns Shift Over 15 Years

An aging Japanese cohort with rheumatoid arthritis saw increasing use of targeted synthetic therapies as glucocorticoid use declined.

MDSpire News

May 08, 2026

Lung Disease Complicates RA Care

Patients with chronic lung disease had numerically lower remission rates and substantially more serious adverse events in a 5-year Japanese registry study of late-onset rheumatoid arthritis.

MDSpire News